Risk Factors for Transplant Outcomes in Children and Adolescents with Non-Malignant Diseases Following Allogeneic Hematopoietic Stem Cell Transplantation
Agnieszka Zaucha‐Prażmo(Medical University of Lublin), Jerzy Kowalczyk(Poznan University of Medical Sciences), Katarzyna Drabko(Medical University of Lublin), Monika Lejman(Medical University of Lublin), Jolanta Goździk(Jagiellonian University), Elżbieta Sadurska(Medical University of Lublin), Robert Dębski(Nicolaus Copernicus University), Jacek Wachowiak(Poznan University of Medical Sciences), Anna Pieczonka(Poznan University of Medical Sciences), Jan Styczyński(Nicolaus Copernicus University), Joanna Zawitkowska(Poznan University of Medical Sciences)
Cited by 14
Related Papers
Creation and analysis of biochemical constraint-based models using the COBRA Toolbox v.3.0
|Nature Protocols|2019|1.4k
Hematopoietic cell transplantation in chronic granulomatous disease: a study of 712 children and adults
|Blood|2020|161
Treosulfan-based conditioning for allogeneic HSCT in children with chronic granulomatous disease: a multicenter experience
|Blood|2016|134
The New Therapeutic Strategies in Pediatric T-Cell Acute Lymphoblastic Leukemia
|International Journal of Molecular Sciences|2021|81
Genetic Biomarkers and Their Clinical Implications in B-Cell Acute Lymphoblastic Leukemia in Children
|International Journal of Molecular Sciences|2022|74